Physician profile

Daniel R Gomez

Radiation Oncology · Houston, TX

NPI 1790944023

$47,163.14

in general payments reported to CMS, 2019-2025

15 companies · $13K in 2025

The $13K reported for 2025 was more than what 97% of Radiation Oncology providers received nationally (typical 2025 total: $172).

Payments by year

General and research payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$30,939.00
Food and Beverage$1,297.41
Travel and Lodging$517.44

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Janssen Research & Development, LLC $11,290.00 2025
Astrazeneca Pharmaceuticals LP $10,305.42 2019-2025 Imfinzi, Tagrisso
Regeneron Pharmaceuticals, INC. $9,380.35 2024 Libtayo
Gyrus Acmi, INC. $6,952.00 2020
Siemens Medical Solutions USA, INC. $5,850.00 2023-2025 Truebeam
Astrazeneca Uk Limited $1,833.19 2024 Imfinzi
Varian Medical Systems, INC. $1,040.00 2020
Ethicon INC. $253.70 2023 Monarch Platform
Amgen INC. $122.88 2022
Novocure INC. $53.66 2024 Optune
Ortho Dermatologics, A Division of Bausch Health US, LLC $29.00 2021-2022
Heron Therapeutics, INC. $27.67 2022
Scpharmaceuticals INC. $25.27 2025

2 companies reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

Research and ownership

$1,560.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Daniel R Gomez

$47,163.14

in general payments reported 2019-2025

Years
2019-2025
Top company
Janssen Research & Development, LLC
Context
The $13K reported for 2025 was more than what 97% of Radiation Oncology providers received nationally (typical 2025 total: $172).

https://glasscript.com/doctor/263262/daniel-r-gomez

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.